QuickSee Free’s combination of the open view design, wavefront aberrometry, and dynamic measurements produces clinically accurate autorefraction measurements, in a durable handheld format suitable for use in your practice and in the field.
The patented Plenoptika Wavefront Refraction Engine performs continuos data analysis, making QuickSee Free as accurate as the high-end clinical desktop autorefractors and demonstrating excellent agreement with subjective refraction.
QuickSee Free technology has been clinically evaluated in five IRB-based studies and documented in seven peer-reviewed publications and conference abstracts. QuickSee Free has FDA Class I 510(k) exempt medical device registration.
Reviews
There are no reviews yet.